These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 22230866

  • 41. Full Resistance and decreased susceptibility to carbapenems in IMP-13-producing Pseudomonas aeruginosa isolates from an outbreak.
    Santella G, Cuirolo A, Almuzara M, Palombarani S, Sly G, Radice M, Gutkind G.
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1381-2. PubMed ID: 20047915
    [No Abstract] [Full Text] [Related]

  • 42. Emergence of metallo-beta-lactamases in the Netherlands.
    Al Naiemi N, Rijnsburger MC, Savelkoul PHM, Vandenbroucke-Grauls CMJ, Debets-Ossenkopp YJ.
    J Med Microbiol; 2009 Oct; 58(Pt 10):1398-1399. PubMed ID: 19574411
    [No Abstract] [Full Text] [Related]

  • 43. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012.
    Sefraoui I, Berrazeg M, Drissi M, Rolain JM.
    Microb Drug Resist; 2014 Apr; 20(2):156-61. PubMed ID: 24320688
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Evaluation of a hospital outbreak related to carbapenem-resistant Pseudomonas aeruginosa].
    Cekin Y, Karagöz A, Kızılateş F, Cekin AH, Oztoprak Çuvalcı N, Bülbüller N, Durmaz R.
    Mikrobiyol Bul; 2013 Oct; 47(4):619-27. PubMed ID: 24237430
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
    Dubois V, Arpin C, Melon M, Melon B, Andre C, Frigo C, Quentin C.
    J Clin Microbiol; 2001 Jun; 39(6):2072-8. PubMed ID: 11376037
    [Abstract] [Full Text] [Related]

  • 50. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan.
    Huang YT, Chang SC, Lauderdale TL, Yang AJ, Wang JT.
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):211-6. PubMed ID: 17521840
    [Abstract] [Full Text] [Related]

  • 51. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN.
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [Abstract] [Full Text] [Related]

  • 52. A CARB-like beta-lactamase gene from a multiple-drug-resistant Pseudomonas aeruginosa clinical isolate in China.
    Wang J, Bo R, Xu L, Mi Z, Wang C.
    J Med Microbiol; 2006 Nov; 55(Pt 11):1609-1610. PubMed ID: 17030927
    [No Abstract] [Full Text] [Related]

  • 53. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
    Najar Peerayeh S, Pirhajati Mahabadi R, Pakbaten Toupkanlou S, Siadat SD.
    Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132
    [Abstract] [Full Text] [Related]

  • 54. Selection of carbapenem-resistant Pseudomonas aeruginosa in a haematology unit?
    Garvey MI, Bradley CW, Biggs MJ, Holden E, Gill MJ.
    J Hosp Infect; 2018 Mar; 98(3):238-240. PubMed ID: 29126992
    [No Abstract] [Full Text] [Related]

  • 55. Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.
    Luzzaro F, Mantengoli E, Perilli M, Lombardi G, Orlandi V, Orsatti A, Amicosante G, Rossolini GM, Toniolo A.
    J Clin Microbiol; 2001 May; 39(5):1865-70. PubMed ID: 11326005
    [Abstract] [Full Text] [Related]

  • 56. Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity.
    Lagatolla C, Edalucci E, Dolzani L, Riccio ML, De Luca F, Medessi E, Rossolini GM, Tonin EA.
    J Clin Microbiol; 2006 Jul; 44(7):2348-53. PubMed ID: 16825348
    [Abstract] [Full Text] [Related]

  • 57. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S.
    J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
    [Abstract] [Full Text] [Related]

  • 58. Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.
    Bubonja-Sonje M, Matovina M, Skrobonja I, Bedenic B, Abram M.
    Microb Drug Resist; 2015 Jun; 21(3):261-9. PubMed ID: 25565041
    [Abstract] [Full Text] [Related]

  • 59. Carbapenem resistance mechanism and risk factors of Pseudomonas aeruginosa clinical isolates from a University Hospital in Xi'an, China.
    Zhang JF, Chen BL, Xin XY, Zhao HB, Wang HY, Song H, Xu ZK.
    Microb Drug Resist; 2009 Mar; 15(1):41-5. PubMed ID: 19226194
    [Abstract] [Full Text] [Related]

  • 60. Clusters of infection due to metallo-β-lactamase-producing Pseudomonas aeruginosa in stem cell transplant and haematology units.
    Paez J, Levin AS, Fu L, Basso M, Fonseca GH, Dulley FL, Rossi F, Guimarães T, Costa SF.
    J Hosp Infect; 2011 Jan; 77(1):76-7. PubMed ID: 21030111
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.